Holistic Healing
Evexias-trained practitioners are more than just certified in preventive medicine—they are deeply rooted in a holistic philosophy that honors the interconnectedness of mind, body, and spirit. With advanced training in functional diagnostics, hormone optimization, and lifestyle medicine, they approach each patient as a whole person, not a collection of symptoms. This integrative model empowers individuals to reclaim vitality, emotional balance, and long-term wellness through personalized, science-backed care that nurtures every dimension of health.
Balance
All Evexias nutraceuticals are pharmaceutical grade, meticulously formulated to meet the highest standards of purity, potency, and bioavailability. Designed to restore the body’s natural balance, these supplements support hormone optimization, immune resilience, and cellular vitality—bridging the gap between nutrition and precision medicine. Each product is backed by clinical research and crafted to complement individualized wellness protocols for optimal functional health outcomes.
Optimal Function
EvexiPEL® bio-identical hormone replacement therapy (BHRT) is designed to help both women and men achieve optimal hormonal balance—without the rollercoaster of highs and lows often seen with conventional hormone therapies. By using plant-derived, bio-identical hormones that closely mimic the body’s natural chemistry, EvexiPEL® supports steady, sustained hormone levels that promote energy, mental clarity, libido, metabolic function, and emotional well-being. This precision-based approach not only alleviates symptoms of hormonal decline but also fosters long-term vitality, disease prevention, and enhanced quality of life through personalized, science-backed care.
Total Health
acked by a prestigious board of integrative and functional medicine physicians, Evexias is redefining the future of total health. Through rigorous practitioner training, evidence-based protocols, and ongoing clinical research, Evexias equips providers with the tools to uncover root causes—not just treat symptoms. Their comprehensive approach blends hormone optimization, nutraceutical support, and lifestyle medicine to empower patients and practitioners alike, transforming care into a proactive, personalized journey toward lifelong wellness.
New Patients
Provide basic contact information and we’ll reach out to schedule!
The Science
"Based on the results of the study, the researchers concluded that, compared with never use or discontinuation of HT before the age of 65 years, the use of estrogen monotherapy beyond age 65 years was associated with significant risk reductions in mortality, breast cancer, lung cancer, colorectal cancer, congestive heart failure, venous thromboembolism, atrial fibrillation, acute myocardial infarction, and dementia."
300 pre and post-menopausal women with symptoms of androgen deficiency were asked to self-administer the 11-item MRS, at baseline and 3 months after their first insertion of the subcutaneous testosterone implant. Both groups demonstrated similar improvement in total score, as well as psychological, somatic and urogenital subscale scores with testosterone therapy.
There is a rising prevalence of hypogonadism in aging men. Low testosterone levels are associated with increased risk factors for cardiovascular disease (CVD), including type 2 diabetes, obesity, and inflammation. This article highlights the effects of testosterone replacement therapy (TRT) on cardiovascular outcomes noting low endogenous bioavailable testosterone levels have been shown to be associated with higher rates of all‐cause and cardiovascular‐related mortality,
Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions
2016 Mayo Clinic
The 2016 Mayo Clinic Proceedings article, authored by an international panel of experts led by Dr. Abraham Morgentaler, presents nine consensus resolutions on testosterone deficiency (TD) and its treatment. The panel affirms that TD is a legitimate, clinically significant condition affecting male health, quality of life, and longevity, and that testosterone therapy (T therapy) is effective and evidence-based. They reject the notion that age alone should limit treatment and emphasize that no specific testosterone level can predict treatment response. Importantly, the consensus finds no credible evidence linking T therapy to increased risks of cardiovascular events or prostate cancer. The article also calls for further research into the potential benefits of T therapy for cardiometabolic diseases like diabetes. This consensus aims to clarify misconceptions, counter media-driven fear, and establish a scientifically grounded foundation for treating TD.
Women's Health Initiative (WHI):Landmark Trial Overstated HRT Risk for Younger Women
2022 WHI significantly overstated risks of HRT
The CMAJ article reveals that the landmark 2002 Women’s Health Initiative (WHI) trial significantly overstated the risks of hormone replacement therapy (HRT) for younger women, leading to widespread fear and a dramatic decline in HRT use. Dr. Robert Langer, a principal investigator, argues that the trial’s early termination and sensationalized reporting distorted the science, particularly by exaggerating breast cancer and heart attack risks that were not statistically significant. The trial was designed for older women, yet its findings were generalized to younger women, despite later data showing that women aged 50–59 had significantly lower risks and even some health benefits from HRT. Experts now acknowledge that this miscommunication caused long-term harm, including increased mortality and fracture rates among women who avoided or discontinued therapy. Medical societies are gradually reversing course, recommending short-term HRT for symptom relief in recently menopausal women, but the damage to public perception and clinical practice has been profound.
If you are ready to start feeling better, scan the QR code above, input your information, and someone will call you to get you started on your health journey.